ATS 2022: An Add-on Reliever-Triggered Inhaled Corticosteroid Strategy Reduces Severe Asthma Exacerbations in a Real-World Study of African American/Black and Hispanic/Latinx Patients With Asthma

165 views
May 24, 2022
0 Comments
Login to view comments. Click here to Login